New understanding about mechanism for cell death after stroke leads to possible therapy

Scientists at the Brain Research Centre, a partnership of the University of British Columbia Faculty of Medicine and Vancouver Coastal Health Research Institute, have uncovered new information about the mechanism by which brain cells die following a stroke, as well as a possible way to mitigate that damage. The results of the study were recently published online in Nature Medicine.

Following a stroke, many brain cells continue to die even after blood flow has been restored. Researchers have long known this is due to a complicated cascade of cellular messages that lead to the “self-destruction” and death of brain cells.

The team of Brain Research Centre scientists discovered that, in animal models, the over-activation of NMDA receptors—special receptors on the surface of brain cells—activates another protein, called SREBP-1, which subsequently causes cell death. SREBP-1 is found naturally in cells throughout the body and is involved with cholesterol and other fat production.

NMDA receptors control the movement of calcium in and out of brain cells, which is necessary for normal brain function. However, following a stroke, levels of glutamate—the most abundant chemical messenger in the brain—rise rapidly in cells, leading to over-activation of NMDA receptors, an excess of calcium entering cells, and the onset of cell death.

The researchers found that under normal conditions, SREBP-1 is largely kept in an inactive form by a protein known as Insig-1. After a stroke, over-activation of NMDA receptors leads to a rapid degradation of Insig-1, which increases the level of active form of SREBP-1.

“How over-activation of NMDA receptors caused cell death after a stroke has been a mystery,” says Dr. Yu Tian Wang, co-lead on the study, a Professor in the UBC Division of Neurology, and the Heart and Stroke Foundation of BC & Yukon Chair in Stroke Research. “We found that SREBP-1 was one of the missing key players in that process.”

While the detailed mechanisms by which activation of SREBP-1 leads to brain cell death remain to be established, the researchers discovered a way to inhibit SREBP-1 and thereby significantly reduce cell death.

“We developed a drug that can stabilize Insig-1, which in turn inhibits the activity of SREBP-1,” says Dr. Max Cynader, co-lead on the study, a Canada Research Chair in Brain Development, and the Director of the Brain Research Centre. “By doing so, we were able to prevent cell death.”

The researchers also found that the drug works post-stroke in animal models. “When we administered it post-stroke, there was less brain cell damage 30 days later than compared to controls,” says Dr. Wang. “This is important because previous studies focused on blocking the NMDA receptors in order to prevent cell death, but this approach didn’t work because it affected normal cell function and had a relatively short therapeutic window. The drug we studied works downstream of NMDA receptors and appears to have less detrimental side effects with a much improved therapeutic window.”

Further investigations will help researchers understand how SREBP-1 causes cell death and to further determine efficacy of the drug. As well, because of the protein’s connection to cholesterol synthesis and other cellular functions, further investigations may reveal if it has a role in other neurological disorders, such as ALS, and whether the drug might be effective for those conditions as well.

###

This study was funded by the Heart & Stroke Foundation of BC & Yukon, the Canadian Institutes of Health Research, and the Cure Huntington’s Disease Initiative Foundation. Stroke is the third leading cause of death in Canada, and the leading cause of long-term adult disability.

The Brain Research Centre comprises more than 225 investigators with multidisciplinary expertise in neuroscience research ranging from the test tube, to the bedside, to industrial spin-offs. The Centre is a partnership of the UBC Faculty of Medicine and Vancouver Coastal Health Research Institute. http://www.brain.ubc.ca

The UBC Faculty of Medicine provides innovative programs in the health and life sciences, teaching students at the undergraduate, graduate and postgraduate levels, and generates more than $200 million in research funding each year. http://www.med.ubc.ca

Vancouver Coastal Health Research Institute (VCHRI) is the research body of Vancouver Coastal Health Authority, which includes BC’s largest academic and teaching health sciences centres: VGH, UBC Hospital, and GF Strong Rehabilitation Centre. In academic partnership with the University of British Columbia, VCHRI brings innovation and discovery to patient care, advancing healthier lives in healthy communities across British Columbia, Canada, and beyond.

Contact: Melissa Ashman

604-827-3396
University of British Columbia

RELATED STORIES:
Stroke Survivors Improve Balance with Tai Chi   EMS programs improve stroke awareness, short-term   Smokers treated for brain aneurysm with coils at higher risk of recurrence   High stroke rate seen in Iran   Lexapro helped preserve brain function after stroke   Transfusions cut stroke risk in sickle cell   Women Less Likely to Have a Stroke After Mini-Stroke   Moderate-to-Heavy Exercise May Reduce Risk of Stroke for Men   How to Prevent a Mini Stroke from Becoming a Major Problem   Argatroban may promote opening of arteries following stroke   Warfarin users appear more likely to develop brain bleeding following stroke treatment   Woman aquires new accent after stroke

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]